An Interview With CureDuchenne Chief Scientific Officer Dr. Michael Kelly

Episode 43  ยท  Aug 15, 2022, 02:04 PM

Headliner
Share
Subscribe

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Michael Kelly, PhD, chief scientific officer at CureDuchenne, on the latest developments in exon skipping, gene therapy and other treatments for Duchenne muscular dystrophy.

Share
Subscribe
Next
An interview with Annie Kennedy, head of policy, advocacy, and patient engagement at the EveryLife Foundation for Rare Diseases
Top episodes
An Interview WIth Tracy Sharp, a Patient With Lambert-Eaton Myasthenic Syndrome
by Rare Care Podcast
An Interview With Omer Abdul Hamid, MD, of Nemours Children's Hospital in Orlando, Florida
by Rare Care Podcast
A Discussion on Medullary Thyroid Carcinoma With Dr. David Goldenberg
by Rare Care Podcast